Intensity TherapeuticsINTS
13F holders, Q2 2024 (June 30)23holders +5
5new positions
0sold out
$4.90avg. 13F price*
At the end of Q2 2024, 23 institutions reported holding Intensity Therapeutics Inc. (INTS) in their 13F filings, up 5 from Q1 2024. 5 opened new positions and 0 sold out. The largest holders were Sapient Capital LLC ($5.0M), Vanguard Group Inc. ($1.0M) and Brown Advisory Inc. ($772K).
- Company
- Intensity Therapeutics Inc.
- CUSIP
- 45828J103
- Latest filing quarter
- Q4 2025
History
Number of 13F holders
Total Exit/New Position Q1 2024 → Q2 2024
| Institutions | Total Value | |
|---|---|---|
| New Positions | 5 | $270K |
| Exits | 0 | $0 |
All 13F filers, Q1 2024 → Q2 2024: 87,605 shares bought and 41,415 shares sold, net +46,190 shares. Counts holders who added, trimmed, opened or closed a position; split-adjusted.
Ownership 23 holders
| Sapient Capital LLC | 0.10% | Reduce -0.1% | 1,010,753 | $5.0M |
| Vanguard Group Inc. | 0.00% | Add +15.7% | 204,975 | $1.0M |
| Brown Advisory Inc. | 0.00% | No change | 157,526 | $772K |
| Sigma Planning Corp | 0.01% | No change | 47,869 | $235K |
| Geode Capital Management, LLC | 0.00% | No change | 47,620 | $233K |
| Mesirow Financial Investment Management, Inc. | 0.00% | No change | 44,177 | $216K |
| Blair William & Co. | 0.00% | New | 37,805 | $185K |
| One Charles Private Wealth Services, LLC | 0.06% | No change | 31,800 | $156K |
| Bison Wealth, LLC | 0.01% | No change | 17,420 | $91K |
| HRT Financial LP | 0.00% | New | 15,863 | $77K |
| State Street Corp. | 0.00% | No change | 14,500 | $71K |
| BlackRock Inc. | 0.00% | Add +29.6% | 13,903 | $68K |
| Rothschild Wealth LLC | 0.02% | Reduce -53.7% | 13,339 | $65K |
| Commonwealth Equity Services, LLC | 0.00% | No change | 10,414 | $51K |
| Wells Fargo & Company | 0.00% | Add +39.0% | 3,450 | $17K |
| UBS Group AG | 0.00% | Add +10.1% | 3,316 | $16K |
| Tower Research Capital LLC (TRC) | 0.00% | Reduce -66.6% | 2,351 | $12K |
| Steward Partners Investment Advisory, LLC | 0.00% | New | 900 | $4K |
| Morgan Stanley | 0.00% | New | 500 | $2K |
| Bank of America Corp. | 0.00% | New | 219 | $1K |
| JPMorgan Chase & Co. | 0.00% | Reduce -99.8% | 18 | $88 |
| Qube Research & Technologies Ltd | 0.00% | Reduce -100.0% | 2 | $10 |
| Royal Bank of Canada | 0.00% | Add +1114.3% | 85 | $0 |
"% of holder's portfolio" is INTS's weight in each manager's 13F, not the share of Intensity Therapeutics Inc. the manager owns.